Renvela (sevelamer carbonate) Powder for Oral Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   March 2016 CONTRAINDICATIONS Renvela is contraindicated in patients with known hypersensitivity to sevelamer carbonate or to...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts